BriaCell to Uplist and Trade on the Toronto Stock Exchange from TSX Venture Exchange under 'BCT'; Remains 'BCTX' on Nasdaq Company News
Lexaria Receives Independent Review Board Approval For DehydraTECH-CBD Human Clinical Study HYPER-H21-4 Biotech Investing
Lifshitz Law Firm, P.C. Announces Investigations of Bristol-Myers Squibb Company , Eargo, Inc. , Hyzon Motors Inc. , Nano-X Imaging Ltd. , and View, Inc. Pharmaceutical Investing
Gilead Announces New England Journal of Medicine Publication of Data Demonstrating Veklury® Significantly Reduced Risk of Hospitalization in High-Risk Patients With COVID-19 Pharmaceutical Investing
